OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome</p>
Mario Ojeda‐Uribe, Valérie Rimelen, Cathérine Marzullo
Journal of Blood Medicine (2020) Vol. Volume 11, pp. 67-72
Open Access | Times Cited: 7
Mario Ojeda‐Uribe, Valérie Rimelen, Cathérine Marzullo
Journal of Blood Medicine (2020) Vol. Volume 11, pp. 67-72
Open Access | Times Cited: 7
Showing 7 citing articles:
Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential
Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 7
Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 7
Acquired von Willebrand syndrome and lymphoid neoplasms: A review of malignancy management, and propositions of practical recommendations
Christophe Nicol, Brigitte Pan‐Petesch, Jean‐Christopher Ianotto
Haemophilia (2022) Vol. 28, Iss. 6, pp. 938-949
Closed Access | Times Cited: 7
Christophe Nicol, Brigitte Pan‐Petesch, Jean‐Christopher Ianotto
Haemophilia (2022) Vol. 28, Iss. 6, pp. 938-949
Closed Access | Times Cited: 7
Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom’s macroglobulinemia
Danqing Kong, Yun Li, Chengcheng Fu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 63, Iss. 2, pp. 491-494
Closed Access | Times Cited: 4
Danqing Kong, Yun Li, Chengcheng Fu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 63, Iss. 2, pp. 491-494
Closed Access | Times Cited: 4
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
María Poza, Rodrigo Íñiguez, Irene Zamanillo, et al.
Therapeutic Advances in Hematology (2021) Vol. 12
Open Access | Times Cited: 2
María Poza, Rodrigo Íñiguez, Irene Zamanillo, et al.
Therapeutic Advances in Hematology (2021) Vol. 12
Open Access | Times Cited: 2
Waldenström’s macroglobulinemia – clinical symptoms and review of therapy yesterday, today and tomorrow
Zdeněk Adam, Luděk Pour, David Zeman, et al.
Klinicka onkologie (2023) Vol. 36, Iss. 3
Open Access
Zdeněk Adam, Luděk Pour, David Zeman, et al.
Klinicka onkologie (2023) Vol. 36, Iss. 3
Open Access
Waldenström´s macroglobulinemia, overview of clinical symptoms, and therapy and our experience with ibrutinib therapy
Zdeněk Adam, David Zeman, Luděk Pour, et al.
Onkologie (2022) Vol. 16, Iss. Suppl. B, pp. 83-102
Open Access
Zdeněk Adam, David Zeman, Luděk Pour, et al.
Onkologie (2022) Vol. 16, Iss. Suppl. B, pp. 83-102
Open Access
